Visual and anatomical outcomes following intravitreal treatment of macular oedema secondary to retinal vein occlusion

被引：0
|
作者：
Tasos, Emmanuel
Sharma, Pavel
Karia, Janvi
Menem, Dheyaedeen
Katzakis, Michail
Minos, Evangelos
机构：
来源：
ACTA OPHTHALMOLOGICA | 2024年 / 102卷
关键词：
D O I：
10.1111/aos.15889
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion
    Kreutzer, T. C.
    Alge, C. S.
    Wolf, A. H.
    Kook, D.
    Burger, J.
    Strauss, R.
    Kunze, C.
    Haritoglou, C.
    Kampik, A.
    Priglinger, S.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (03) : 351 - 355
  • [2] Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion
    Guenduez, K.
    Bakri, S. J.
    [J]. EYE, 2008, 22 (09) : 1168 - 1171
  • [3] Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion
    K Gündüz
    S J Bakri
    [J]. Eye, 2008, 22 : 1168 - 1171
  • [4] Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study
    Kriechbaum, K.
    Michels, S.
    Prager, F.
    Georgopoulos, M.
    Funk, M.
    Geitzenauer, W.
    Schmidt-Erfurth, U.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (04) : 518 - 522
  • [5] Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
    Cheng, K-C
    Wu, W-C
    Chen, K-J
    [J]. EYE, 2009, 23 (11) : 2024 - 2032
  • [6] Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion
    Spandau, Ulrich H. M.
    Ihloff, Anna K.
    Jonas, Jost B.
    [J]. ACTA OPHTHALMOLOGICA SCANDINAVICA, 2006, 84 (04): : 555 - 556
  • [7] Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
    K-C Cheng
    W-C Wu
    K-J Chen
    [J]. Eye, 2009, 23 : 2023 - 2033
  • [8] Analysis of intravitreal bevacizumab treatment for macular oedema due to retinal vein occlusion
    Balla, Szabolcs
    Zold, Eszter
    Potor, Laszlo
    Lukucz, Balazs
    Vajas, Attila
    Ujhelyi, Bernadett
    Nagy, Valeria
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (05) : 2528 - 2534
  • [9] Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion
    Hikichi, Taiichi
    Higuchi, Makoto
    Matsushita, Takuro
    Kosaka, Shoko
    Matsushita, Reiko
    Takami, Kinnitaka
    Ohtsuka, Hideo
    Kitamei, Hirokuni
    Shioya, Shoko
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (02) : 195 - 199
  • [10] Two-year outcomes of intravitreal (IVT) ranibizumab for macular oedema secondary to branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO)
    Juma, Z.
    Tyagi, P.
    Santiago, C.
    Ionean, A.
    [J]. EYE, 2017, 31 : S16 - S16
12345